GHK-Cu · research summary

The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.

Redox biology · 2024. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

Mixed-methods study involving a human observational cohort and animal/cell-based experimental models
“An experimental silicosis mouse model was established to observe the effects of GHK-Cu on lung inflammation and fibrosis. Moreover, the effects of GHK-Cu on the alveolar macrophages (AM) were examined using the RAW264.7 cell line.”

Subjects

Patients with silicosis, healthy controls, mice, and RAW264.7 macrophage cells
“Patients with silicosis (n = 15) and age-matched healthy controls (n = 11) were recruited in the China-Japan Friendship Hospital between December 2021 and March 2022.”

Sample size

26 human participants (15 patients, 11 controls) and 5 mice per group for histological analysis
“Patients with silicosis (n = 15) and age-matched healthy controls (n = 11) were recruited in the China-Japan Friendship Hospital between December 2021 and March 2022.”

Duration

Human recruitment occurred between December 2021 and March 2022; animal exposure lasted 28 days
“Patients with silicosis (n = 15) and age-matched healthy controls (n = 11) were recruited in the China-Japan Friendship Hospital between December 2021 and March 2022.”

Reported findings

Plasma GHK levels were significantly lower in silicosis patients and positively correlated with lung function metrics
“Our data show that the plasma GHK levels of patients with silicosis were lower (35.67 ± 13.69 ng/mL vs. 105.50 ± 31.94 ng/mL, p < 0.0001) (Fig. 1A) than those of healthy subjects.”
GHK-Cu treatment attenuated lung inflammation and fibrosis in silicosis mice
“The morphological examinations revealed that GHK-Cu markedly alleviated the alveolar lesions, pulmonary injury, and fibrosis caused by CS stimulation (Fig. 2A and B).”
GHK-Cu binds to PRDX6 to reduce oxidative stress in macrophages
“Our results demonstrate that GHK-Cu indeed exerts antioxidant effects in macrophages by targeting PRDX6.”

Limitations stated by the authors

Use of the RAW264.7 cell line instead of primary alveolar macrophages for all experiments
“However, we have to be aware that using RAW264.7 cell line rather than primary alveolar macrophages is one of the limitations of this study because we did not validate all the experiments with primary AMs.”

Source: PubMed 38879894 · DOI 10.1016/j.redox.2024.103237 · all study summaries

Study type

Mixed-methods study involving a human observational cohort and animal/cell-based experimental models

“An experimental silicosis mouse model was established to observe the effects of GHK-Cu on lung inflammation and fibrosis. Moreover, the effects of GHK-Cu on the alveolar macrophages (AM) were examined using the RAW264.7 cell line.”

Reported findings

Plasma GHK levels were significantly lower in silicosis patients and positively correlated with lung function metrics

“Our data show that the plasma GHK levels of patients with silicosis were lower (35.67 ± 13.69 ng/mL vs. 105.50 ± 31.94 ng/mL, p < 0.0001) (Fig. 1A) than those of healthy subjects.”

GHK-Cu treatment attenuated lung inflammation and fibrosis in silicosis mice

“The morphological examinations revealed that GHK-Cu markedly alleviated the alveolar lesions, pulmonary injury, and fibrosis caused by CS stimulation (Fig. 2A and B).”

GHK-Cu binds to PRDX6 to reduce oxidative stress in macrophages

“Our results demonstrate that GHK-Cu indeed exerts antioxidant effects in macrophages by targeting PRDX6.”

Limitations stated by the authors

Use of the RAW264.7 cell line instead of primary alveolar macrophages for all experiments

“However, we have to be aware that using RAW264.7 cell line rather than primary alveolar macrophages is one of the limitations of this study because we did not validate all the experiments with primary AMs.”